**Core Concept**
During pregnancy, the management of generalized tonic-clonic seizures (GTCS) requires careful consideration of the safety profile of antiepileptic drugs (AEDs) for both the mother and the fetus. The goal is to maintain seizure control while minimizing the risk of teratogenic effects.

**Why the Correct Answer is Right**
Lamotrigine is generally considered a safe and effective option for the management of GTCS during pregnancy. Its mechanism of action involves blocking voltage-dependent sodium channels, which stabilizes neuronal membranes and decreases the release of excitatory neurotransmitters. Lamotrigine has a relatively favorable safety profile, with a low risk of teratogenic effects and no significant association with congenital malformations. Additionally, lamotrigine is not known to cause significant hematological, hepatic, or renal adverse effects.

**Why Each Wrong Option is Incorrect**
**Option B:** Carbamazepine (CBZ) is not typically recommended as a first-line treatment for GTCS during pregnancy due to its potential for teratogenic effects, including neural tube defects and craniofacial abnormalities.

**Option D:** Valproate is contraindicated in pregnancy, particularly during the first trimester, due to its high risk of congenital malformations, including neural tube defects, craniofacial abnormalities, and cardiac defects. Valproate also increases the risk of fetal hydantoin syndrome.

**Clinical Pearl / High-Yield Fact**
When managing GTCS in pregnancy, it's essential to weigh the benefits and risks of each AED carefully and consider the patient's individual circumstances, including her seizure type, frequency, and history of AED exposure.

**Correct Answer:**
✓ Correct Answer: A. Lamotrigine